Ameriprise’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Sell
193,429
-12,455
-6% -$1.12M ﹤0.01% 1544
2025
Q4
$18M Buy
205,884
+13,355
+7% +$1.01M ﹤0.01% 1494
2025
Q3
$11M Sell
192,529
-12,644
-6% -$728K ﹤0.01% 1849
2025
Q2
$12.1M Buy
205,173
+40,090
+24% +$2.59M ﹤0.01% 1677
2025
Q1
$12.1M Buy
165,083
+23,234
+16% +$1.92M ﹤0.01% 1629
2024
Q4
$11.7M Buy
141,849
+16,479
+13% +$1.3M ﹤0.01% 1678
2024
Q3
$8.97M Sell
125,370
-8,583
-6% -$606K ﹤0.01% 1882
2024
Q2
$9.17M Sell
133,953
-3,583
-3% -$214K ﹤0.01% 1819
2024
Q1
$7.38M Sell
137,536
-3,010
-2% -$162K ﹤0.01% 2063
2023
Q4
$7.49M Sell
140,546
-17,519
-11% -$854K ﹤0.01% 2032
2023
Q3
$7.85M Sell
158,065
-49,603
-24% -$2.77M ﹤0.01% 1905
2023
Q2
$12.4M Buy
207,668
+82,616
+66% +$4.71M ﹤0.01% 1601
2023
Q1
$7.08M Buy
125,052
+11,859
+10% +$760K ﹤0.01% 2057
2022
Q4
$8.41M Sell
113,193
-6,507
-5% -$443K ﹤0.01% 1886
2022
Q3
$7.13M Sell
119,700
-13,311
-10% -$802K ﹤0.01% 1963
2022
Q2
$7.47M Sell
133,011
-554,545
-81% -$36.5M ﹤0.01% 1990
2022
Q1
$50.7M Buy
687,556
+6,411
+0.9% +$446K 0.02% 803
2021
Q4
$49.2M Buy
681,145
+751
+0.1% +$54.5K 0.01% 852
2021
Q3
$52.1M Sell
680,394
-505,100
-43% -$40.6M 0.02% 755
2021
Q2
$91.9M Sell
1,185,494
-7,966
-0.7% -$566K 0.03% 558
2021
Q1
$73.6M Sell
1,193,460
-515,158
-30% -$32.6M 0.02% 609
2020
Q4
$111M Buy
1,708,618
+219,807
+15% +$12.6M 0.04% 439
2020
Q3
$73.7M Buy
1,488,811
+32,110
+2% +$1.66M 0.03% 507
2020
Q2
$69.5M Sell
1,456,701
-14,944
-1% -$721K 0.03% 500
2020
Q1
$62.6M Buy
1,471,645
+506,005
+52% +$25M 0.03% 466
2019
Q4
$57.1M Buy
965,640
+145,801
+18% +$7.92M 0.02% 638
2019
Q3
$41.9M Buy
819,839
+203,127
+33% +$9.67M 0.02% 748
2019
Q2
$26.1M Buy
616,712
+417,615
+210% +$18.1M 0.01% 987
2019
Q1
$9.84M Sell
199,097
-5,717
-3% -$259K ﹤0.01% 1717
2018
Q4
$8.86M Sell
204,814
-17,174
-8% -$857K ﹤0.01% 1702
2018
Q3
$364M Sell
221,988
-16,734
-7% -$881K 0.13% 179
2018
Q2
$12M Sell
238,722
-38,607
-14% -$2.01M 0.01% 1588
2018
Q1
$13.8M Sell
277,329
-44,939
-14% -$2.11M 0.01% 1389
2017
Q4
$13.2M Buy
322,268
+16,213
+5% +$568K 0.01% 1386
2017
Q3
$9.1M Sell
306,055
-30,188
-9% -$922K ﹤0.01% 1653
2017
Q2
$11.2M Buy
336,243
+102,280
+44% +$3.21M 0.01% 1447
2017
Q1
$6.95M Buy
233,963
+22,468
+11% +$613K ﹤0.01% 1787
2016
Q4
$5.25M Sell
211,495
-869,494
-80% -$19.8M ﹤0.01% 2013
2016
Q3
$24.4M Sell
1,080,989
-15,892
-1% -$374K 0.01% 819
2016
Q2
$26.1M Buy
1,096,881
+102,178
+10% +$2.45M 0.02% 770
2016
Q1
$23.6M Sell
994,703
-161,025
-14% -$3.94M 0.01% 819
2015
Q4
$32.2M Sell
1,155,728
-177,610
-13% -$4.46M 0.02% 658
2015
Q3
$27.5M Sell
1,333,338
-199,616
-13% -$5.06M 0.02% 733
2015
Q2
$39.3M Buy
1,532,954
+240,945
+19% +$6.1M 0.02% 618
2015
Q1
$32.6M Buy
1,292,009
+6,212
+0.5% +$151K 0.02% 718
2014
Q4
$30.6M Buy
+1,285,797
New +$28.5M 0.02% 729
2014
Q3
Sell
-52,629
Closed -$1.26M 5833
2014
Q2
$1.26M Sell
52,629
-17,865
-25% -$431K ﹤0.01% 2695
2014
Q1
$1.87M Buy
70,494
+17,958
+34% +$427K ﹤0.01% 2510
2013
Q4
$1.06M Sell
52,536
-2,914
-5% -$54.1K ﹤0.01% 2643
2013
Q3
$968K Buy
55,450
+806
+1% +$13.9K ﹤0.01% 2697
2013
Q2
$921K Buy
+54,644
New +$843K ﹤0.01% 2636

Other funds holding GMED

Ameriprise's GMED Position: Q1 2026 in Review

Ameriprise reduced its Globus Medical (GMED) stake by 6% in Q1 2026, selling an estimated $1.12M and leaving 193,429 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

Ameriprise first reported a position in GMED in Q2 2013 and has held it in 51 quarters since. The position peaked at $364M in Q3 2018. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Ameriprise held 193,429 shares of Globus Medical worth $16.7M as of Q1 2026.
  • Ameriprise sold 12,455 Globus Medical shares in Q1 2026, an estimated $1.12M.
  • Globus Medical made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1544 holding.
  • Ameriprise first reported a position in Globus Medical in Q2 2013 and has held it in 51 quarters since.
  • Ameriprise's Globus Medical position peaked at $364M in Q3 2018.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.